We are thrilled to see the announcement from the Safety Pharmacology Society that the 2024 Distinguished Service Award (DSA) recipient is Dr. Norman Stockbridge! Dr. Stockbridge has been a member of the HESI Cardiac Safety Committee since 2000.
Dr. Stockbridge is being recognized for his significant contributions to shaping regulatory safety pharmacology practices globally, benefiting safety scientists, and facilitating the safe progression of drugs into humans. He is also recognized for his groundbreaking leadership in framing CiPA and related activities under HESI; Dr. Stockbridge's efforts were pivotal in developing the ICH E14/S7B Q&As. Lastly, his dedication to education, development, training, and mentorship has empowered countless scientists at the FDA and institutions worldwide. Please join us in extending our congratulations to Dr. Stockbridge on his recognition.
Dr. Stockbridge has been invited to give his DSA Presentation (topic TBD) on September 25, 2024 in San Diego, CA during the SPS 2024 Annual Meeting.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.